Ecully, France · Founded 2003 · Privately Held (backing)
Manufacturer of pharmaceutical ingredients and specialty ingredients based in Ecully, France. Seqens is based in Ecully, France and was founded in 2003. Its last reported valuation was $1.6 billion in Nov 2022. It has raised $544 million.
Last reported valuation
$1.6B
Oct 2026
Priced at
—
Total raised
$543.8M
Last round
—
Team — not yet on record
No current team members for Seqens are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Seqens with a free account
·Watch Seqens: the Monday email on marks, rounds and moves
